Plakous Therapeutics, founded with a mission to combat inflammation-driven diseases through regenerative biotherapeutics, focuses on utilizing cytokines and growth factors derived from human placenta. Their vision is to become a global leader in the commercialization of safe and effective birth tissue biotherapeutics. The company is dedicated to developing in situ restorative and regenerative healing solutions, targeting a wide range of conditions from infancy to old age.
The team at Plakous Therapeutics includes notable experts in the fields of biotechnology and regenerative medicine. The company has garnered attention for its innovative approach and potential impact on the healthcare industry. By leveraging the unique properties of human placental extracts, Plakous aims to revolutionize treatment paradigms for various inflammatory diseases, marking significant strides in both research and clinical applications.
